Literature DB >> 28780609

Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).

I Yaya1,2, P Roux3,4, F Marcellin3,4, D Salmon-Ceron5, M P Carrieri3,4.   

Abstract

Mesh：

Year:  2017        PMID： 28780609     DOI： 10.1007/s10620-017-4703-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

Review 1.  Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy.

Authors:  Lynn E Taylor; Tracy Swan; Gail V Matthews
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

2.  Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.

Authors:  John B Dever; Julie H Ducom; Ariel Ma; Joseph Nguyen; Lin Liu; Ann Herrin; Erik J Groessl; Samuel B Ho
Journal:  Dig Dis Sci       Date:  2017-04-04       Impact factor: 3.199

Review 3.  Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.

Authors:  Jason Grebely; Megan Oser; Lynn E Taylor; Gregory J Dore
Journal:  J Infect Dis       Date:  2013-03       Impact factor: 5.226

4.  Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.

Authors:  P Bruggmann; L Falcato; S Dober; B Helbling; O Keiser; F Negro; D Meili
Journal:  J Viral Hepat       Date:  2008-07-10       Impact factor: 3.728

5.  Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).

Authors:  Dominique Salmon-Ceron; Julien Cohen; Maria Winnock; Perrine Roux; Firouze Bani Sadr; Eric Rosenthal; Isabelle Poizot Martin; Marc-Arthur Loko; Marion Mora; Philippe Sogni; Bruno Spire; François Dabis; Maria Patrizia Carrieri
Journal:  BMC Health Serv Res       Date:  2012-03-12       Impact factor: 2.655

6.  Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure.

Authors:  Cornelia Metzig; Julian Surey; Marie Francis; Jim Conneely; Ibrahim Abubakar; Peter J White
Journal:  Sci Rep       Date:  2017-05-12       Impact factor: 4.379

7.  Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting.

Authors:  Christina Kim; Thomas Kerr; Kathy Li; Ruth Zhang; Mark W Tyndall; Julio S G Montaner; Evan Wood
Journal:  BMC Public Health       Date:  2009-07-29       Impact factor: 3.295
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.